午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

2(1H)-Quinolinone, 6,6'-[[4-(1-cyclohexyl-1H-tetrazol-5-yl)butylidene]bis(oxy)]bis[3,4-dihydro-

2(1H)-Quinolinone, 6,6'-[[4-(1-cyclohexyl-1H-tetrazol-5-yl)butylidene]bis(oxy)]bis[3,4-dihydro- Struktur
934533-79-6
CAS-Nr.
934533-79-6
Englisch Name:
2(1H)-Quinolinone, 6,6'-[[4-(1-cyclohexyl-1H-tetrazol-5-yl)butylidene]bis(oxy)]bis[3,4-dihydro-
Synonyma:
Cilostazol Impurity 17;Cilostazol Impurity 2Q: What is Cilostazol Impurity 2 Q: What is the CAS Number of Cilostazol Impurity 2
CBNumber:
CB58395963
Summenformel:
C29H34N6O4
Molgewicht:
530.62
MOL-Datei:
934533-79-6.mol

2(1H)-Quinolinone, 6,6'-[[4-(1-cyclohexyl-1H-tetrazol-5-yl)butylidene]bis(oxy)]bis[3,4-dihydro- Eigenschaften

Siedepunkt:
881.0±65.0 °C(Predicted)
Dichte
1.43±0.1 g/cm3(Predicted)
pka
13.79±0.20(Predicted)

Sicherheit

2(1H)-Quinolinone, 6,6'-[[4-(1-cyclohexyl-1H-tetrazol-5-yl)butylidene]bis(oxy)]bis[3,4-dihydro- Chemische Eigenschaften,Einsatz,Produktion Methoden

2(1H)-Quinolinone, 6,6'-[[4-(1-cyclohexyl-1H-tetrazol-5-yl)butylidene]bis(oxy)]bis[3,4-dihydro- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

2(1H)-Quinolinone, 6,6'-[[4-(1-cyclohexyl-1H-tetrazol-5-yl)butylidene]bis(oxy)]bis[3,4-dihydro- Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 6)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TOSUN PHARM 020-61855200 13326451905
 260366801@qq.com China 7885 58
Guangzhou Dreampharm Biotechnology Co., Ltd. 020-36607679 17825480238
 3008233746@qq.com China 9934 12
Jinan blalong chemical co. LTD 2710913286@.com
 1513643261@qq.com China 14246 58
Shanghai Zerui Biotechnology Co., Ltd. 021-54580889 18321124657
 731997554@qq.com China 10608 58
Changzhou Xianglong Pharmaceutical Technology Co., Ltd., 18915873328
296197970@qq.com China 11055 58
  • Cilostazol Impurity 2Q: What is Cilostazol Impurity 2 Q: What is the CAS Number of Cilostazol Impurity 2
  • Cilostazol Impurity 17
  • 934533-79-6
Copyright 2019 ? ChemicalBook. All rights reserved